Concepedia

Wolfgang Seghezzi

WS

34

Publications

3.6K

Citations

28

H-Index

1991

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cellular Research (United States)

École Polytechnique Fédérale de Lausanne

Institut de Biologie Moléculaire et Cellulaire

Harvard University

Wolfgang Seghezzi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1991–2020

34

Publications

34

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

David Parry, Timothy J. Guzi, Nicole R. Davis et al. · Molecular Cancer Therapeutics · 2010 · 553 citations · Full text

, , +16

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

John B. Mumm, Jan Emmerich, Xueqing Zhang et al. · Cancer Cell · 2011 · 402 citations · Full text

, , +5

The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation

Annette O. Walter, Wolfgang Seghezzi, Wouter Korver et al. · Oncogene · 2000 · 291 citations

, , +13

Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis

Changyu Wang, Katrin F. Chua, Wolfgang Seghezzi et al. · Genes & Development · 1998 · 193 citations · Full text

, , +14

Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Kamil Paruch, Michael P. Dwyer, Carmen Álvarez et al. · ACS Medicinal Chemistry Letters · 2010 · 174 citations · Full text

, , +21

Rows per page

1–5 of 34